Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...

Due to the rise in demand, counterfeit versions of portable AC units have surfaced online. Experts strongly recommend ...

Winnipeg’s technology sector is experiencing steady and sustained growth, with a new generation of startups helping to ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Synthetic data has long been used to create larger training sets for AI while preserving privacy and protecting sensitive ...

With the UK Government targeting a three-fold increase of offshore wind power to 50GW by 2030, there is an urgent need for ...

Step into a kitchen inspired by the past and you might be surprised by what’s trending again. Cabinet styles from the 1980s, ...

Rezpeg's promising Phase 2b data makes Nektar Therapeutics a strong contender in the AD market. Click here to read an ...

The Canadian government has made changes to which educational programs can lead to a work permit upon graduation. On 25 June, ...

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...